WO2016022412A8 - Immunogenic composition against campylobacter jejuni - Google Patents

Immunogenic composition against campylobacter jejuni Download PDF

Info

Publication number
WO2016022412A8
WO2016022412A8 PCT/US2015/043070 US2015043070W WO2016022412A8 WO 2016022412 A8 WO2016022412 A8 WO 2016022412A8 US 2015043070 W US2015043070 W US 2015043070W WO 2016022412 A8 WO2016022412 A8 WO 2016022412A8
Authority
WO
WIPO (PCT)
Prior art keywords
campylobacter jejuni
immunogenic composition
composition against
against campylobacter
jejuni
Prior art date
Application number
PCT/US2015/043070
Other languages
French (fr)
Other versions
WO2016022412A1 (en
WO2016022412A9 (en
Inventor
Patricia Guerry
Mario Artur Monteiro
Original Assignee
The United States Of America As Represented By The Secretary Of The Navy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/733,114 external-priority patent/US9999591B2/en
Application filed by The United States Of America As Represented By The Secretary Of The Navy filed Critical The United States Of America As Represented By The Secretary Of The Navy
Priority to EP15830474.1A priority Critical patent/EP3188748A4/en
Priority to JP2017506284A priority patent/JP6530051B2/en
Priority to AU2015301368A priority patent/AU2015301368B2/en
Priority to CA2957430A priority patent/CA2957430C/en
Publication of WO2016022412A1 publication Critical patent/WO2016022412A1/en
Publication of WO2016022412A9 publication Critical patent/WO2016022412A9/en
Publication of WO2016022412A8 publication Critical patent/WO2016022412A8/en
Priority to AU2018204255A priority patent/AU2018204255B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The inventive subject matter relates to an immunogenic composition against Campylobacter jejuni comprising isolated capsule polysaccharide from selected pathogenic Campylobacter jejuni strains. The inventive subject matter also relates to methods of using the polysaccharide compositions in inducing and anti-C. jejuni immune response.
PCT/US2015/043070 2014-08-07 2015-07-31 Immunogenic composition against campylobacter jejuni WO2016022412A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP15830474.1A EP3188748A4 (en) 2014-08-07 2015-07-31 Immunogenic composition against campylobacter jejuni
JP2017506284A JP6530051B2 (en) 2014-08-07 2015-07-31 Immunogenic composition for Campylobacter jejuni
AU2015301368A AU2015301368B2 (en) 2014-08-07 2015-07-31 Immunogenic composition against Campylobacter jejuni
CA2957430A CA2957430C (en) 2014-08-07 2015-07-31 Immunogenic composition against campylobacter jejuni
AU2018204255A AU2018204255B2 (en) 2014-08-07 2018-06-14 Immunogenic composition against Campylobacter jejuni

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US201462034436P 2014-08-07 2014-08-07
US62/034,436 2014-08-07
US201462054454P 2014-09-24 2014-09-24
US62/054,454 2014-09-24
US201562127927P 2015-03-04 2015-03-04
US62/127,927 2015-03-04
US201562165301P 2015-05-22 2015-05-22
US62/165,301 2015-05-22
US14/733,114 2015-06-08
US14/733,114 US9999591B2 (en) 2005-09-21 2015-06-08 Immunogenic composition against Campylobacter jejuni

Publications (3)

Publication Number Publication Date
WO2016022412A1 WO2016022412A1 (en) 2016-02-11
WO2016022412A9 WO2016022412A9 (en) 2016-05-12
WO2016022412A8 true WO2016022412A8 (en) 2017-04-20

Family

ID=55264367

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2015/043070 WO2016022412A1 (en) 2014-08-07 2015-07-31 Immunogenic composition against campylobacter jejuni

Country Status (5)

Country Link
EP (1) EP3188748A4 (en)
JP (1) JP6530051B2 (en)
AU (2) AU2015301368B2 (en)
CA (1) CA2957430C (en)
WO (1) WO2016022412A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2328697T5 (en) * 2003-06-02 2017-07-25 Novartis Vaccines And Diagnostics, Inc. Immunogenic compositions based on microparticles comprising adsorbed toxoid and an antigen containing a polysaccharide
WO2007038122A2 (en) * 2005-09-21 2007-04-05 The United States Of America As Represented By The Secretary Of The Navy Immunogenic capsule composition for use as a vaccine component against campylobacter jejuni
WO2009017666A1 (en) * 2007-07-27 2009-02-05 The United States Of America As Represented By The Secretary Of The Navy Capsule composition for use as immunogen against campylobacter jejuni
US9308246B2 (en) * 2010-05-28 2016-04-12 The United States Of America As Represented By The Secretary Of The Navy Capsule composition for use as immunogen against Campylobacter jejuni
AU2015321698B2 (en) * 2014-09-24 2018-06-28 The United States Of America As Represented By The Secretary Of The Navy Combined enterotoxigenic Escherichia coli and Campylobacter jejuni recombinant construct

Also Published As

Publication number Publication date
AU2015301368A1 (en) 2017-02-09
EP3188748A1 (en) 2017-07-12
WO2016022412A1 (en) 2016-02-11
JP6530051B2 (en) 2019-06-12
AU2015301368B2 (en) 2018-04-05
CA2957430C (en) 2021-01-12
WO2016022412A9 (en) 2016-05-12
JP2017524710A (en) 2017-08-31
AU2018204255A1 (en) 2018-07-05
CA2957430A1 (en) 2016-02-11
AU2018204255B2 (en) 2019-04-18
EP3188748A4 (en) 2018-04-18

Similar Documents

Publication Publication Date Title
HUS2200035I1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
EA201990566A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
WO2017095944A8 (en) Methods and compositions relating to chondrisomes from blood products
WO2015168379A3 (en) Combination vaccine devices and methods of killing cancer cells
WO2015132669A3 (en) Anti-foam compositions
WO2016094837A3 (en) Anti-c10orf54 antibodies and uses thereof
WO2016019134A8 (en) Flagellin-based agents and uses including effective vaccination
WO2015177591A3 (en) Capsule and device for preparing beverages and method for manufacturing a capsule
WO2016004068A8 (en) Hydrogel compositions comprising encapsulated cells and methods of use thereof
WO2016077397A3 (en) Anti-pd-1 antibodies, compositions comprising anti-pd-1 antibodies and methods of using anti-pd-1 antibodies
HK1251250A1 (en) Bifidobacteria as probiotic foundation species of gut microbiota
WO2016014434A3 (en) Anti-cd74 antibodies, compositions comprising anti-cd74 antibodies and methods of using anti-cd74 antibodies
MX2017000776A (en) Modified meningococcal fhbp polypeptides.
WO2016179034A3 (en) Methods and compositions for stimulating immune response using potent immunostimulatory rna motifs
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
MX2018002901A (en) Process for preparing an attenuated tetravalent dengue vaccine.
MX2017009682A (en) Broth compositions and their use as prebiotics.
WO2016100615A3 (en) Methods and composition for neutralization of influenza
EP3324963A4 (en) Methods and compositions for enhancing immune response to vaccination
MX2019005535A (en) Streptococcus thermophilus for use in preparation of fermented products.
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions
WO2017196140A3 (en) Aquaculture functional feedstuff additive comprising lactococcus lactis bfe920 strain inducing immunomodulatory t-cell.
RS62793B1 (en) Anticancer heterobasidion annosum extract, compositions and uses thereof
WO2015149016A3 (en) Breast and ovarian cancer vaccines
WO2016022412A8 (en) Immunogenic composition against campylobacter jejuni

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15830474

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2017506284

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2957430

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2015301368

Country of ref document: AU

Date of ref document: 20150731

Kind code of ref document: A

REEP Request for entry into the european phase

Ref document number: 2015830474

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2015830474

Country of ref document: EP